1 - 25 of 28 results for author:"Sakashita H." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Yoshida T., Akahoshi F., Sakashita H., Kitajima H., Nakamura M., Sonda S., Takeuchi M., Tanaka Y., Ueda N., Sekiguchi S. et al. Bioorg. Med. Chem. 20:5705-5719(2012) · Mapped (1) |
| Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group. Yoshida T., Akahoshi F., Sakashita H., Sonda S., Takeuchi M., Tanaka Y., Nabeno M., Kishida H., Miyaguchi I., Hayashi Y. Bioorg. Med. Chem. 20:5033-5041(2012) · Mapped (1) |
| Structural basis for telmisartan-mediated partial activation of PPAR gamma. Amano Y., Yamaguchi T., Ohno K., Niimi T., Orita M., Sakashita H., Takeuchi M. Hypertens. Res. 35:715-719(2012) · Mapped (2) |
| Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity. Inoue H., Miyazaki Y., Kikuchi K., Yoshida N., Ide F., Ohmori Y., Tomomura A., Sakashita H., Kusama K. Tumour Biol. 33:183-194(2012) · Mapped (3) |
| Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1. Aoki K., Kakizaki F., Sakashita H., Manabe T., Aoki M., Taketo M.M. Cancer Res. 71:593-602(2011) · Mapped (23) |
| IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. Fukuda M., Ehara M., Suzuki S., Ohmori Y., Sakashita H. Int. J. Oncol. 36:1355-1365(2010) · Mapped (7) |
| Expression of heparanase: a possible role in invasiveness and aggressive clinical behavior of ameloblastomas. Gonzalez-Alva P., Kikuchi K., Miyazaki Y., Okamoto E., Oku Y., Tsuchiya H., Noguchi Y., Sakashita H., Ide F., Kusama K. J Oral Sci 52:39-47(2010) · Mapped (4) |
| Significance of podoplanin expression in keratocystic odontogenic tumor. Okamoto E., Kikuchi K., Miyazaki Y., Gonzalez-Alva P., Oku Y., Tanaka A., Yoshida N., Fujinami M., Ide F., Sakashita H. et al. J. Oral Pathol. Med. 39:110-114(2010) · Mapped (3) |
| Enhanced expression of podoplanin in ameloblastomas. Gonzalez-Alva P., Tanaka A., Oku Y., Miyazaki Y., Okamoto E., Fujinami M., Yoshida N., Kikuchi K., Ide F., Sakashita H. et al. J. Oral Pathol. Med. 39:103-109(2010) · Mapped (3) |
| The significance of podoplanin expression in human inflamed gingiva. Miyazaki Y., Okamoto E., Gonzalez-Alva P., Hayashi J., Ishige T., Kikuchi K., Nemoto N., Shin K., Sakashita H., Ochiai K. et al. J Oral Sci 51:283-287(2009) · Mapped (3) |
| Identification of a key element for hydrogen-bonding patterns between protein kinases and their inhibitors. Katayama N., Orita M., Yamaguchi T., Hisamichi H., Kuromitsu S., Kurihara H., Sakashita H., Matsumoto Y., Fujita S., Niimi T. |
| CD133+CD44+ population efficiently enriches colon cancer initiating cells. Haraguchi N., Ohkuma M., Sakashita H., Matsuzaki S., Tanaka F., Mimori K., Kamohara Y., Inoue H., Mori M. Ann. Surg. Oncol. 15:2927-2933(2008) · Mapped (6) |
| A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Mimori K., Fukagawa T., Kosaka Y., Ishikawa K., Iwatsuki M., Yokobori T., Hirasaki S., Takatsuno Y., Sakashita H., Ishii H. et al. Ann. Surg. Oncol. 15:2934-2942(2008) · Mapped (5) |
| Loss of CYLD might be associated with development of salivary gland tumors. Fukuda M., Hiroi M., Suzuki S., Ohmori Y., Sakashita H. Oncol. Rep. 19:1421-1427(2008) · Mapped (5) |
| FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Miyagawa-Hayashino A., Tsuruyama T., Egawa H., Haga H., Sakashita H., Okuno T., Toyokuni S., Tamaki K., Yamabe H., Manabe T. et al. Am. J. Pathol. 171:1499-1508(2007) · Mapped (3) |
| Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation. Akaiwa K., Akashi H., Harada H., Sakashita H., Hiromatsu S., Kano T., Aoyagi S. Brain Res. 1122:47-55(2006) · Mapped (2) |
| Induction of apoptosis in human salivary gland tumor cells by anti-NCAM antibody. Fukuda M., Horiuchi Y., Oku Y., Ishikawa M., Suka N., Suzuki S., Kusama K., Sakashita H. Oncol. Rep. 14:1143-1149(2005) · Mapped (4) |
| Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor. Ide F., Suka N., Kitada M., Sakashita H., Kusama K., Ishikawa T. Cancer Lett. 214:35-41(2004) · Mapped (14) |
| Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity. Fukuda M., Tanaka A., Hamao A., Suzuki S., Kusama K., Sakashita H. Oncol. Rep. 12:259-267(2004) · Mapped (4) |
| Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. Yasuda S., Arii S., Mori A., Isobe N., Yang W., Oe H., Fujimoto A., Yonenaga Y., Sakashita H., Imamura M. J. Hepatol. 40:117-123(2004) · Mapped (22) |
| p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Ide F., Kitada M., Sakashita H., Kusama K., Tanaka K., Ishikawa T. Am. J. Pathol. 163:1729-1733(2003) · Mapped (14) |
| EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland. Koyama N., Kashimata M., Sakashita H., Sakagami H., Gresik E.W. Dev. Dyn. 227:216-226(2003) · Mapped (65) |
| NMR structure of human fibronectin EDA. Niimi T., Osawa M., Yamaji N., Yasunaga K., Sakashita H., Mase T., Tanaka A., Fujita S. J. Biomol. NMR 21:281-284(2001) · UniProtKB (1) |
| Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis. Ide F., Oda H., Nakatsuru Y., Kusama K., Sakashita H., Tanaka K., Ishikawa T. Carcinogenesis 22:567-572(2001) · Mapped (14) |
| Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography. Orita M., Yamamoto S., Katayama N., Aoki M., Takayama K., Yamagiwa Y., Seki N., Suzuki H., Kurihara H., Sakashita H. et al. J. Med. Chem. 44:540-547(2001) · UniProtKB (1) |